1. Home
  2. CEE vs ANEB Comparison

CEE vs ANEB Comparison

Compare CEE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEE
  • ANEB
  • Stock Information
  • Founded
  • CEE 1990
  • ANEB 2020
  • Country
  • CEE Germany
  • ANEB United States
  • Employees
  • CEE N/A
  • ANEB N/A
  • Industry
  • CEE Finance Companies
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CEE Finance
  • ANEB Health Care
  • Exchange
  • CEE Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • CEE 105.5M
  • ANEB 90.4M
  • IPO Year
  • CEE N/A
  • ANEB 2021
  • Fundamental
  • Price
  • CEE $16.19
  • ANEB $2.37
  • Analyst Decision
  • CEE
  • ANEB Buy
  • Analyst Count
  • CEE 0
  • ANEB 2
  • Target Price
  • CEE N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • CEE 22.0K
  • ANEB 129.6K
  • Earning Date
  • CEE 01-01-0001
  • ANEB 11-12-2025
  • Dividend Yield
  • CEE 3.86%
  • ANEB N/A
  • EPS Growth
  • CEE N/A
  • ANEB N/A
  • EPS
  • CEE N/A
  • ANEB N/A
  • Revenue
  • CEE N/A
  • ANEB N/A
  • Revenue This Year
  • CEE N/A
  • ANEB N/A
  • Revenue Next Year
  • CEE N/A
  • ANEB N/A
  • P/E Ratio
  • CEE N/A
  • ANEB N/A
  • Revenue Growth
  • CEE N/A
  • ANEB N/A
  • 52 Week Low
  • CEE $7.80
  • ANEB $0.80
  • 52 Week High
  • CEE $10.32
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • CEE 47.59
  • ANEB 50.03
  • Support Level
  • CEE $15.87
  • ANEB $1.77
  • Resistance Level
  • CEE $16.45
  • ANEB $2.26
  • Average True Range (ATR)
  • CEE 0.56
  • ANEB 0.19
  • MACD
  • CEE -0.08
  • ANEB -0.05
  • Stochastic Oscillator
  • CEE 41.32
  • ANEB 53.10

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: